Skip to content
WeighLab

Head-to-head · Cost-Efficiency Index

TeleClinic vs Sipra

Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.

Higher scoreGrade C

TeleClinic

Shoppers outside California, New Jersey and South Carolina who want a cheap first month and a rate that's locked as the dose goes up.

Visit TeleClinic
VS
Grade C

Sipra

Shoppers ready to commit to at least three months who want a price that doesn't rise with the dose and a full price table before they start.

Visit Sipra

The verdict

Too close to callGrade C vs C

TeleClinic and Sipra tie on the Cost-Efficiency Index at 78/100, so neither wins outright on the numbers, so choose on fit. TeleClinic: Shoppers outside California, New Jersey and South Carolina who want a cheap first month and a rate that's locked as the dose goes up. Sipra: Shoppers ready to commit to at least three months who want a price that doesn't rise with the dose and a full price table before they start.

Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs TeleClinic.

Factor by factor

Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.

Normalized Cost/Month

70
64

Price Transparency

97
97

Nationwide Access

78
86

Formulation Options

66
77

Clinical Oversight

85
78

Contract Flexibility

67
61

Pricing, coverage & formulary

The disclosed facts behind the scores. Lower price wins its row (teal).

SpecTeleClinicSipra
Cost-Efficiency Index78/10078/100
Semaglutide / mo$199/moCompounded, standard monthly rate, same at every dose; $79 first month$189/mo3-month plan, $567 charged up front, same price at every dose, compounded
Tirzepatide / mo$299/moCompounded, standard monthly rate, same at every dose; $149 first month$249/mo3-month plan, $747 charged up front, same price at every dose, compounded
Semaglutide / yr (modeled)$2,388$2,268
Tirzepatide / yr (modeled)$3,588$2,988
Coverage47 statesAll 50 states
Oral / sublingualNoYes
Brand-name accessCompounded onlyCompounded only
Rank here#51#52

TeleClinic

78/100

Where the value is

  • Names its pharmacy (Rush Pharmacy, a 503A compounder) and its physician network (LocumTele)
  • Price-lock: the monthly rate stays the same as your dose increases, for as long as you're a member
  • Publishes a full list of the 47 states it serves

The tradeoffs

  • The $79 and $149 headline prices cover only the first month; after that it's $199 and $299, or $139 and $219 a month for the first quarter if you pay quarterly
  • Not available in California, New Jersey or South Carolina
Visit TeleClinic

Full TeleClinic review →

Sipra

78/100

Where the value is

  • A full price table by drug and plan length is published, and the price stays the same as your dose goes up
  • Your card isn't charged until a licensed physician reviews and approves your treatment
  • Injections, lower-dose microdose injections and dissolving tablets are all offered for both drugs

The tradeoffs

  • There's no month-to-month option for GLP-1s: the shortest plan is three months, charged in one payment ($567 for semaglutide, $747 for tirzepatide)
  • To stop the next order you have to cancel at least 13 days before your paid period ends
Visit Sipra

Full Sipra review →

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.

Keep comparing

← All head-to-head comparisons